OXZGEN Performance 25 mg Hemp Derived CBD + Teacrine + recall
OXZGEN Performance 25 mg Hemp Derived CBD + Teacrine + BCAA Orange Flavored, 5 blast caps, 2.2 FL OZ
Why was OXZGEN Performance 25 mg Hemp Derived CBD + Teacrine + recalled?
Yellow #6 is not declared on ingredient label. Label claim for B2 is incorrect (contains 5 mg not 10 mg as stated).
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
10097902, 10186904, 10235905, and 10278906
- Product
- OXZGEN Performance 25 mg Hemp Derived CBD + Teacrine + BCAA Orange Flavored, 5 blast caps, 2.2 FL OZ
- Recalling firm
- Hall Global, LLC
- Quantity
- 1007 packages of 5 count caps
- Distribution
- Contract Manufacturer sends products to distribution centers owned by clients or direct to client company for distribution via internet to end product user.
- Recall date
- October 30, 2019
- Classification
- Class II
- Status
- Terminated
- Agency
- FDA (food)